Follow Us

News Details

Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19

About Proteostasis Therapeutics, Inc.
  • NASDAQ: $PTI
  • Notified: $1.44
  • 07:02 EDT

Price Chart